Andy Pasternak - Jul 29, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP and Chief Business Officer
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Jul 29, 2022
Transactions value $
-$400,483
Form type
4
Date filed
7/29/2022, 05:21 PM
Previous filing
Jun 13, 2022
Next filing
Nov 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Sale -$347K -4.21K -10.82% $82.44 34.7K Jul 29, 2022 Direct F1, F2
transaction HZNP Ordinary Shares Sale -$53.7K -643 -1.85% $83.45 34K Jul 29, 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2022.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.05 to $82.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.10 to $83.57 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.